BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32896073)

  • 1. Liraglutide treatment improves endothelial function in the Ldlr-/- mouse model of atherosclerosis and affects genes involved in vascular remodelling and inflammation.
    Bjørnholm KD; Skovsted GF; Mitgaard-Thomsen A; Rakipovski G; Tveden-Nyborg P; Lykkesfeldt J; Povlsen GK
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):103-114. PubMed ID: 32896073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background.
    Hofmann A; Brunssen C; Poitz DM; Langbein H; Strasser RH; Henle T; Ravens U; Morawietz H
    Atheroscler Suppl; 2017 Nov; 30():294-302. PubMed ID: 29096854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.
    Ganbaatar B; Fukuda D; Salim HM; Nishimoto S; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Sata M
    Atherosclerosis; 2018 Aug; 275():124-132. PubMed ID: 29902700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response.
    Melgar-Lesmes P; Sánchez-Herrero A; Lozano-Juan F; de la Torre Hernández JM; Montell E; Jiménez W; Edelman ER; Balcells M
    Thromb Haemost; 2018 Jul; 118(7):1329-1339. PubMed ID: 29874688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
    Gaspari T; Liu H; Welungoda I; Hu Y; Widdop RE; Knudsen LB; Simpson RW; Dear AE
    Diab Vasc Dis Res; 2011 Apr; 8(2):117-24. PubMed ID: 21562063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote Effects of Transplanted Perivascular Adipose Tissue on Endothelial Function and Atherosclerosis.
    Horimatsu T; Patel AS; Prasad R; Reid LE; Benson TW; Zarzour A; Ogbi M; Bruder do Nascimento T; Belin de Chantemele E; Stansfield BK; Lu XY; Kim HW; Weintraub NL
    Cardiovasc Drugs Ther; 2018 Oct; 32(5):503-510. PubMed ID: 30097828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K
    Bar A; Kus K; Manterys A; Proniewski B; Sternak M; Przyborowski K; Moorlag M; Sitek B; Marczyk B; Jasztal A; Skórka T; Franczyk-Żarów M; Kostogrys RB; Chlopicki S
    Vascul Pharmacol; 2019; 122-123():106581. PubMed ID: 31421222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
    Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature.
    Ellis A; Cheng ZJ; Li Y; Jiang YF; Yang J; Pannirselvam M; Ding H; Hollenberg MD; Triggle CR
    Eur J Pharmacol; 2008 Dec; 601(1-3):111-7. PubMed ID: 18996368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction and permeability via the mitogen-activated protein kinase pathway in a rabbit model of atherosclerosis.
    Ding J; Li Z; Li L; Ding Y; Wang D; Meng S; Zhou Q; Gui S; Wei W; Zhu H; Wang Y
    Biomed Pharmacother; 2020 Aug; 128():110258. PubMed ID: 32516749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
    Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function.
    Park K; Li Q; Evcimen ND; Rask-Madsen C; Maeda Y; Maddaloni E; Yokomizo H; Shinjo T; St-Louis R; Fu J; Gordin D; Khamaisi M; Pober D; Keenan H; King GL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):92-101. PubMed ID: 29162603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR; Moulton KS; Kazlauskas A
    Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice.
    Ewing MM; de Vries MR; Nordzell M; Pettersson K; de Boer HC; van Zonneveld AJ; Frostegård J; Jukema JW; Quax PH
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):95-101. PubMed ID: 20947818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
    Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice.
    Bar A; Targosz-Korecka M; Suraj J; Proniewski B; Jasztal A; Marczyk B; Sternak M; Przybyło M; Kurpińska A; Walczak M; Kostogrys RB; Szymonski M; Chlopicki S
    J Am Heart Assoc; 2019 Mar; 8(6):e011171. PubMed ID: 30866689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.